Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Morere

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|October 3, 1987
[Regression of microangiopathic hemolytic anemia under antineoplastic chemotherapy]J F Morere, S Delanian, J L Breau, et al.
Cancer|July 15, 1987
Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapyP Piedbois, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|June 9, 1984
[Schwartz-Bartter syndrome induced by chemotherapy]J F Morere, P Abastado, J L Breau, et al.
Presse Medicale (Paris, France : 1983)|April 4, 1992
[Rapid complete regression of liver, brain and bone metastases from previously treated breast cancer, with combination of platin, fluorouracil and lomustine]L Israel, J L Breau, J F Morere, et al.
Bulletin Du Cancer|January 1, 1991
[Brain metastases of malignant melanomas]C Boaziz, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|April 2, 1988
[Post-traumatic breast cancer: 14 cases. Biological interpretation]L Israel, J L Breau, J F Morere, et al.
European Journal of Nuclear Medicine|February 1, 1995
Can nuclear medicine predict response to chemotherapy?J L Moretti, M Caglar, M Duran-Cordobes, et al.
Annales De Medecine Interne|January 1, 1985
[Inhibition of DNA repair, major objective of anticancer chemotherapy. Apropos of 680 cases with continuous platin bleomycin combination]L Israël, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1989
[Antalgic effect of calcitonin in bone metastases of cancers]I Pihan, V Cour, J L Breau, et al.
Acta Medica Austriaca|January 1, 1989
Intracavitary 5-fluoro-uracil (5-FU) in combination with systemic chemotherapyJ F Morere, S Delanian, C Boaziz, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|October 3, 1987
[Regression of microangiopathic hemolytic anemia under antineoplastic chemotherapy]J F Morere, S Delanian, J L Breau, et al.
Cancer|July 15, 1987
Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapyP Piedbois, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|June 9, 1984
[Schwartz-Bartter syndrome induced by chemotherapy]J F Morere, P Abastado, J L Breau, et al.
Presse Medicale (Paris, France : 1983)|April 4, 1992
[Rapid complete regression of liver, brain and bone metastases from previously treated breast cancer, with combination of platin, fluorouracil and lomustine]L Israel, J L Breau, J F Morere, et al.
Bulletin Du Cancer|January 1, 1991
[Brain metastases of malignant melanomas]C Boaziz, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|April 2, 1988
[Post-traumatic breast cancer: 14 cases. Biological interpretation]L Israel, J L Breau, J F Morere, et al.
European Journal of Nuclear Medicine|February 1, 1995
Can nuclear medicine predict response to chemotherapy?J L Moretti, M Caglar, M Duran-Cordobes, et al.
Annales De Medecine Interne|January 1, 1985
[Inhibition of DNA repair, major objective of anticancer chemotherapy. Apropos of 680 cases with continuous platin bleomycin combination]L Israël, J L Breau, J F Morere, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1989
[Antalgic effect of calcitonin in bone metastases of cancers]I Pihan, V Cour, J L Breau, et al.
Acta Medica Austriaca|January 1, 1989
Intracavitary 5-fluoro-uracil (5-FU) in combination with systemic chemotherapyJ F Morere, S Delanian, C Boaziz, et al.
Pageof 5